Sunday, September 28, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Porsche’s Electric Vehicle Strategy Stalls, Sending Shockwaves Through Volkswagen Group

Andreas Sommer by Andreas Sommer
September 28, 2025
in Stocks
0
Porsche Holding Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

The ambitious electric vehicle roadmap at luxury automaker Porsche AG has hit significant roadblocks, creating substantial financial headwinds for its parent company, Volkswagen Group, and major shareholder Porsche Holding. This marks the fourth profit warning issued this year, raising serious concerns about the financial stability of the entire corporate family.

Financial Forecasts Slashed Amid Waning EV Demand

Faltering consumer interest in key global markets and intense competitive pressure in China have forced Porsche AG to postpone the launch of several planned all-electric models. In a dramatic revision of its financial outlook, the sports car manufacturer now anticipates an operating margin of no more than 2% for 2025, a sharp decline from its previous projection of 5% to 7%. This strategic pivot necessitates significantly higher depreciation and provisions, estimated to reach up to 1.8 billion euros.

The repercussions extend directly to the Volkswagen Group, which anticipates a financial impact of approximately 5.1 billion euros from this comprehensive product overhaul. Consequently, Volkswagen has also been compelled to lower its own profit margin guidance to a range of 2% to 3%.

Should investors sell immediately? Or is it worth buying Porsche Holding?

Porsche Holding Faces Substantial Earnings Downgrade

As the single largest shareholder in Volkswagen Group, Porsche Holding is experiencing a direct and severe deterioration in its financial prospects. The holding company has issued a major correction to its own projected annual post-tax profit. The new forecast has been adjusted downward to a range of 900 million to 2.9 billion euros, a substantial reduction from the earlier estimate of 1.6 billion to 3.6 billion euros. The market responded immediately to this news, with the company’s shares declining.

This situation at Porsche underscores the immense pressure facing the entire automotive industry. The transition to electric mobility is proving to be more costly and complex than initially anticipated, particularly for premium brands. Porsche Holding’s fortunes remain intrinsically linked to these sector-wide challenges, leaving investors to question its ability to navigate the ongoing turbulence. Recent developments suggest a prolonged period of difficulty for all entities involved.

Ad

Porsche Holding Stock: Buy or Sell?! New Porsche Holding Analysis from September 28 delivers the answer:

The latest Porsche Holding figures speak for themselves: Urgent action needed for Porsche Holding investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 28.

Porsche Holding: Buy or sell? Read more here...

Tags: Porsche Holding
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Adverum Biotechnologies Stock
Stocks

Adverum Biotechnologies: A Critical Juncture for the Biotech Stock

September 28, 2025
Community Healthcare Stock
Stocks

Is Community Healthcare Trust’s Rural Focus a Shield Against Market Volatility?

September 28, 2025
Unitedhealth Stock
Stocks

UnitedHealth’s Strategic Moves Signal Potential Turnaround

September 28, 2025
Next Post
Nevro Stock

Nevro Shares Face Mounting Pressure as Fundamentals Worsen

AMD Stock

AMD's Strategic Alliance with Cohere: A Calculated Challenge to Nvidia's AI Dominance

Commercial Vehicle Stock

US Tariff Move Sparks Hope for Commercial Vehicle Group's Recovery

Recommended

Deutsche Bank Stock

Deutsche Bank Rejoins Europe’s Premier Index After Seven-Year Absence

6 days ago
Leggett & Platt Stock

Market Confidence Wanes as Leggett & Platt Faces Mounting Headwinds

7 days ago
Applied Blockchain Stock

Applied Blockchain Stock Soars to Record High on Major AI Data Center Deal

2 weeks ago
Protara Therapeutics Stock

Protara Therapeutics: A Study in Contrasts Amid Financial Backing and Market Pressure

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Edap TMS Shares: A Puzzling Dip Amidst Strong Fundamentals

Rogers Stock: Is a Turnaround Possible After Years of Stagnation?

eBay’s Strategic Push to Capture the Next Generation of Shoppers

Apple Stock Charts Its Own Course Amid Market Weakness

Fluent Shares Show Signs of Life Amid Conflicting Market Signals

ClearSign Ignites Investor Interest with Major Contracts and Technical Momentum

Trending

Adverum Biotechnologies Stock
Stocks

Adverum Biotechnologies: A Critical Juncture for the Biotech Stock

by Andreas Sommer
September 28, 2025
0

Adverum Biotechnologies finds itself at a pivotal moment, navigating a complex landscape defined by promising clinical progress,...

Community Healthcare Stock

Is Community Healthcare Trust’s Rural Focus a Shield Against Market Volatility?

September 28, 2025
Unitedhealth Stock

UnitedHealth’s Strategic Moves Signal Potential Turnaround

September 28, 2025
Edap TMS Stock

Edap TMS Shares: A Puzzling Dip Amidst Strong Fundamentals

September 28, 2025
Rogers Stock

Rogers Stock: Is a Turnaround Possible After Years of Stagnation?

September 28, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Adverum Biotechnologies: A Critical Juncture for the Biotech Stock
  • Is Community Healthcare Trust’s Rural Focus a Shield Against Market Volatility?
  • UnitedHealth’s Strategic Moves Signal Potential Turnaround

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com